Discover open access scientific publications

Search, annotate, share and cite publications

Publications by ANETTE L. SØNDERGAARD

54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Related publications

1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

983-P: Effect and Safety of Flexible Dose Adjustment With Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Oral Semaglutide in the Management of Type 2 Diabetes: A Report on the Evidence to Date

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Linagliptin Added to Sulphonylurea in Uncontrolled Type 2 Diabetes Patients With Moderate-To-Severe Renal Impairment

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Clinical Outcomes and Health Care Costs Combining Metformin With Sitagliptin or Sulphonylureas or Thiazolidinediones in Uncontrolled Type 2 Diabetes Patients

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2014English

Free Fatty Acid Kinetics During Long-Term Treatment With Pioglitazone Added to Sulfonylurea or Metformin in Type 2 Diabetes

Journal of Internal Medicine
Internal Medicine
2009English

Cost-Utility Analysis of Liraglutide Compared With Sulphonylurea or Sitagliptin, All as Add-On to Metformin Monotherapy in Type 2 Diabetes Mellitus

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy